作者：
Pushpakom, Sudeep [1]
;
Iorio, Francesco [2]
;
Eyers, Patrick A. [3]
;
Escott, K. Jane [4]
;
Hopper, Shirley [5]
;
Wells, Andrew [6]
;
Doig, Andrew [7]
;
Guilliams, Tim [8]
;
Latimer, Joanna [9]
;
McNamee, Christine [10]
;
Norris, Alan [11]
;
Sanseau, Philippe ;
Cavalla, David ;
Pirmohamed, Munir
作者单位：
GlaxoSmithKline R&D, Target Sci, Med Res Ctr, Stevenage, Herts, England
[1]
Med & Healthcare Prod Regulatory Agcy MHRA, Licensing Div, London, England
[2]
Harrison Goddard Foote Patent & Trademark Attorne, Manchester, Lancs, England
[3]
AstraZeneca, IMED Biotech Unit, Sci Partnering & Alliances, Emerging Innovat Unit, Cambridge
[4]
Univ Manchester, Manchester Inst Biotechnol, Fac Sci & Engn, Manchester, Lancs, England
[5]
Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England
[6]
Healx Ltd, St Johns Innovat Ctr, Cambridge, England
[7]
Numedicus Ltd, Cambridge, England
[8]
Univ Liverpool, Dept Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool, Merseyside, England
[9]
MRC, London, England
[10]
Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England
[11]
发布时间
2020-07-29
换一批
